Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
PLoS One ; 13(5): e0197165, 2018.
Article in English | MEDLINE | ID: mdl-29746542

ABSTRACT

DBP5, also known as DDX19, GLE1 and inositol hexakisphosphate (IP6) function in messenger RNA (mRNA) export at the cytoplasmic surface of the nuclear pore complex in eukaryotic cells. DBP5 is a DEAD-box RNA helicase, and its activity is stimulated by interactions with GLE1 and IP6. In addition, these three factors also have unique role(s). To investigate how these factors influenced the cytoplasmic mRNA expression and cell phenotype change, we performed RNA microarray analysis to detect the effect and function of DBP5, GLE1 and IP6 on the cytoplasmic mRNA expression. The expression of some cytoplasmic mRNA subsets (e.g. cell cycle, DNA replication) was commonly suppressed by the knock-down of DBP5, GLE1 and IPPK (IP6 synthetic enzyme). The GLE1 knock-down selectively reduced the cytoplasmic mRNA expression required for mitotic progression, results in an abnormal spindle phenotype and caused the delay of mitotic process. Meanwhile, G1/S cell cycle arrest was observed in DBP5 and IPPK knock-down cells. Several factors that function in immune response were also down-regulated in DBP5 or IPPK knock-down cells. Thereby, IFNß-1 mRNA transcription evoked by poly(I:C) treatment was suppressed. These results imply that DBP5, GLE1 and IP6 have a conserved and individual function in the cytoplasmic mRNA expression. Variations in phenotype are due to the difference in each function of DBP5, GLE1 and IPPK in intracellular mRNA metabolism.


Subject(s)
DEAD-box RNA Helicases/metabolism , G1 Phase , Nucleocytoplasmic Transport Proteins/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Phytic Acid/metabolism , RNA, Messenger/metabolism , S Phase , Biological Transport, Active/genetics , Cytoplasm/genetics , Cytoplasm/metabolism , DEAD-box RNA Helicases/genetics , HeLa Cells , Humans , Interferon-beta/genetics , Interferon-beta/metabolism , Nucleocytoplasmic Transport Proteins/genetics , Phosphotransferases (Alcohol Group Acceptor)/genetics , RNA, Messenger/genetics
3.
Genes (Basel) ; 6(1): 124-49, 2015 Mar 20.
Article in English | MEDLINE | ID: mdl-25802992

ABSTRACT

In eukaryotic cells, RNAs are transcribed in the nucleus and exported to the cytoplasm through the nuclear pore complex. The RNA molecules that are exported from the nucleus into the cytoplasm include messenger RNAs (mRNAs), ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), small nuclear RNAs (snRNAs), micro RNAs (miRNAs), and viral mRNAs. Each RNA is transported by a specific nuclear export receptor. It is believed that most of the mRNAs are exported by Nxf1 (Mex67 in yeast), whereas rRNAs, snRNAs, and a certain subset of mRNAs are exported in a Crm1/Xpo1-dependent manner. tRNAs and miRNAs are exported by Xpot and Xpo5. However, multiple export receptors are involved in the export of some RNAs, such as 60S ribosomal subunit. In addition to these export receptors, some adapter proteins are required to export RNAs. The RNA export system of eukaryotic cells is also used by several types of RNA virus that depend on the machineries of the host cell in the nucleus for replication of their genome, therefore this review describes the RNA export system of two representative viruses. We also discuss the NPC anchoring-dependent mRNA export factors that directly recruit specific genes to the NPC.

4.
Biosci Biotechnol Biochem ; 76(6): 1248-51, 2012.
Article in English | MEDLINE | ID: mdl-22790958

ABSTRACT

A number of proteins complete mRNA processing in the nucleus, thus, inhibitor of mRNA processing is worth finding to analyze the mechanism of mRNA maturation in detail. Here, we established a monitoring system for mRNA processing using a test compound, spliceostatin A (SSA), which inhibits mRNA splicing. This system should serve to facilitate the discovery of novel compounds from natural resources that inhibit mRNA processing.


Subject(s)
Biological Assay , Cell Nucleus/drug effects , Pyrans/pharmacology , RNA Splicing/drug effects , RNA, Messenger/antagonists & inhibitors , Spiro Compounds/pharmacology , Cell Nucleus/genetics , Cell Nucleus/metabolism , Dose-Response Relationship, Drug , Gene Expression/drug effects , Genes, Reporter , HeLa Cells , Humans , Luciferases, Renilla , RNA Precursors/antagonists & inhibitors , RNA Precursors/genetics , RNA Splicing/genetics , RNA, Messenger/genetics , Spliceosomes/drug effects , Spliceosomes/genetics
SELECTION OF CITATIONS
SEARCH DETAIL